All articles
Tissue Necrosis Factor (TNF)
Tuberculosis Associated with Infliximab, a TNF–Neutralizing Agent – (10-18-01)
James Bogash
Tuberculosis Associated with Infliximab, a TNF–Neutralizing Agent
It’s always interesting to see articles come out in different journals that all seem to revolve around a common theme. In this case, we see that the new “wonder drug” for Crohn’s and RA may have some severe side effects. I could accept these side effects in some patient if there were no alternative. However, with many autoimmune diseases, there are many options such as elimination diets, fasting and oral tolerance that can help control the disease.
NEJM — Abstracts: Keane et al. 345 (15): 1098
